Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
240
Enrollment
NIH
Sponsor class
Conditions
Osteopenia
Osteoporosis
Interventions
DRUG:
Alendronate
DRUG:
Estrogen/progestin therapy
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)